Note
We would like to draw your attention to the new General Terms and Agreements at Gynemed, which take effect on 01. January 2019. Passage 3 (prices) has been adjusted.
The changed terms and conditions in detail you can read here.
We would like to draw your attention to the new General Terms and Agreements at Gynemed, which take effect on 01. January 2019. Passage 3 (prices) has been adjusted.
The changed terms and conditions in detail you can read here.
Big News: We’re Growing!
Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics
product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.
✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service
We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.
Learn More About the Acquisition
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information